SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.

Andere talen Shanghai Yizhong Pharmaceutical Co., Ltd.

Aandelen

688091

CNE1000050F4

slotkoers Shanghai S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
37,42 ^CNY	-10,90%		-7,08%	-41,53%

30/04	Aandelen Chinese vasteland noteren lager in aanloop naar lange Dag van de Arbeid, Hongkong stijgt	RE
29/04	Shanghai Yizhong Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	30/04
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Yizhong Pharmaceutical Starts Construction of Paclitaxel Polymer Micelles Production Facility; Shares Down 3%	05/02
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29-10-23
Yizhong Pharmaceutical's Plant Passes Good Manufacturing Practice Inspection of Shanghai's Drug Regulator	27-10-23
Shanghai Yizhong Pharmaceutical Co., Ltd.(XSSC:688091) added to S&P Global BMI Index	18-09-23
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2023.	09-09-23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17-08-23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25-04-23
Chinese Oncology Body Includes Yizhong Pharma's Drug in Non-Small Cell Lung Cancer Treatment Guidelines	24-04-23
Yizhong Pharma Gets Nod to Trial Lung Cancer Drug in China	17-04-23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27-02-23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	19-10-22
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange A Share Index	09-09-22
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange Composite Index	09-09-22
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2022.	09-09-22
Shanghai Yizhong Pharmaceutical’s CFO Steps Down; Successor Named	18-08-22
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	17-08-22
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	17-04-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shanghai Yizhong Pharmaceutical Co., Ltd.

Aandelen

688091

CNE1000050F4

Andere talen

Filters